https://nl.marketscreener.com/koers/aandeel/ARCH-THERAPEUTICS-INC-120795248/nieuws/Arch-Therapeutics-Inc-geeft-een-update-over-de-commercialisering-van-het-eerste-product-AC5-Advan-44841581/?utm_source=telegram&utm_medium=social&utm_campaign=share